Oct 15 (Reuters)-
AFC-HD Ams Life Science Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Aug 31, 2025 Aug 31, 2024 Aug 31, 2026 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 32.66 30.19 34.14 16.73
(+8.2 pct) (+18.0 pct) (+4.5 pct) (+0.7 pct)
Operating 2.41 1.92 2.55 1.30
(+25.7 pct) (+17.1 pct) (+5.6 pct) (+0.1 pct)
Recurring 2.44 1.92 2.45 1.33
(+27.2 pct) (+16.2 pct) (+0.1 pct) (+0.1 pct)
Net
Net 1.45 1.25 1.46 883 mln
(+15.7 pct) (+13.6 pct) (+1.0 pct) (+0.1 pct)
EPS 102.98 yen 89.20 yen 103.73 yen 59.11 yen
EPS Diluted 102.97 yen 89.11 yen
Ann Div 34.00 yen 30.00 yen 36.00 yen
-Q2 Div 16.00 yen 15.00 yen 18.00 yen
-Q4 Div 18.00 yen 15.00 yen 18.00 yen
NOTE - AFC-HD Ams Life Science Co Ltd.
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2927.T